Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
07 October 1983Website:
http://www.anixa.comNext earnings report:
12 March 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 01 Nov 2024 23:55:33 GMTDividend
Analysts recommendations
Institutional Ownership
ANIX Latest News
SAN JOSE, Calif. , Oct. 31, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced its presentation at the Sidoti Micro-Cap Virtual Conference, taking place November 13-14, 2024.
Announces focus on therapeutic approach; resulting in a faster and more cost-effective path to approval SAN JOSE, Calif. , Sept. 24, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced its strategic plan for a Phase 2 study for its breast cancer vaccine.
SAN JOSE, Calif. , July 17, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Cleveland Clinic, has received a "Decision to Grant" notice from the Japan Patent Office (JPO) for the patent application titled "Vaccine Adjuvants and Formulations.
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company specializing in cancer treatment and prevention, will be participating in the Sidoti Micro-Cap Virtual Conference on May 8-9, 2024.
Some of the most explosive opportunities can be found in biotech stocks. Look at CRISPR Therapeutics (NASDAQ: CRSP ), for example.
FATE reports better-than-expected third-quarter 2023 financial results, driven by lower operating expenses. The stock rises about 5% in the after-market hours.
ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The United States Treasury Secretary, Janet Yellen, recently expressed her confidence in the economy's ability to recover from the recession without causing significant harm to the job market or sparking excessive inflation. She believes that the United States will successfully navigate this economic challenge, maintaining control over consumer-price increases.This is leading to many investors considering cheap stocks to buy.
ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.
What type of business is Anixa Biosciences?
Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
What sector is Anixa Biosciences in?
Anixa Biosciences is in the Healthcare sector
What industry is Anixa Biosciences in?
Anixa Biosciences is in the Biotechnology industry
What country is Anixa Biosciences from?
Anixa Biosciences is headquartered in United States
When did Anixa Biosciences go public?
Anixa Biosciences initial public offering (IPO) was on 07 October 1983
What is Anixa Biosciences website?
https://www.anixa.com
Is Anixa Biosciences in the S&P 500?
No, Anixa Biosciences is not included in the S&P 500 index
Is Anixa Biosciences in the NASDAQ 100?
No, Anixa Biosciences is not included in the NASDAQ 100 index
Is Anixa Biosciences in the Dow Jones?
No, Anixa Biosciences is not included in the Dow Jones index
When was Anixa Biosciences the previous earnings report?
No data
When does Anixa Biosciences earnings report?
The next expected earnings date for Anixa Biosciences is 12 March 2025